DE60302268D1 - Fungizide Zubereitung und Methoden zu ihrer Herstellung und Verwendung - Google Patents

Fungizide Zubereitung und Methoden zu ihrer Herstellung und Verwendung

Info

Publication number
DE60302268D1
DE60302268D1 DE60302268T DE60302268T DE60302268D1 DE 60302268 D1 DE60302268 D1 DE 60302268D1 DE 60302268 T DE60302268 T DE 60302268T DE 60302268 T DE60302268 T DE 60302268T DE 60302268 D1 DE60302268 D1 DE 60302268D1
Authority
DE
Germany
Prior art keywords
drug
preferred
preparation
emulsion layer
emulsifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60302268T
Other languages
English (en)
Other versions
DE60302268T2 (de
Inventor
Fang-Yu Lee
Shan-Chiung Chen
Ping-Kuen Chen
Han-Chiang Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yung Shin Pharm Industries Co Ltd
Original Assignee
Yung Shin Pharm Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yung Shin Pharm Industries Co Ltd filed Critical Yung Shin Pharm Industries Co Ltd
Application granted granted Critical
Publication of DE60302268D1 publication Critical patent/DE60302268D1/de
Publication of DE60302268T2 publication Critical patent/DE60302268T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60302268T 2002-04-05 2003-03-24 Fungizide Zubereitung und Methoden zu ihrer Herstellung und Verwendung Expired - Fee Related DE60302268T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/115,994 US6673373B2 (en) 2001-02-01 2002-04-05 Antifungal formulation and the methods for manufacturing and using the same
US115994 2002-04-05

Publications (2)

Publication Number Publication Date
DE60302268D1 true DE60302268D1 (de) 2005-12-22
DE60302268T2 DE60302268T2 (de) 2006-08-03

Family

ID=28041076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302268T Expired - Fee Related DE60302268T2 (de) 2002-04-05 2003-03-24 Fungizide Zubereitung und Methoden zu ihrer Herstellung und Verwendung

Country Status (7)

Country Link
US (1) US6673373B2 (de)
EP (1) EP1350508B8 (de)
JP (1) JP2003300907A (de)
KR (1) KR20030079766A (de)
CN (1) CN1303982C (de)
AT (1) ATE309790T1 (de)
DE (1) DE60302268T2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
WO2004012714A1 (en) * 2002-08-05 2004-02-12 Dsm Ip Assets B.V. Oral dosage forms of water insoluble drugs and methods of making the same
WO2004050068A1 (en) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
EP1438960B2 (de) † 2003-01-14 2012-12-19 Acino Pharma AG Zusammensetzung in Form eines festen Dispersion enthaltend Itraconazol und ein hydrophilisches Polymer mit einer verbesserten Bioverfügbarkeit
PT1438961E (pt) † 2003-01-14 2007-05-31 Cimex Pharma Ag Composição bioquivalente de itraconazol disperso num polímero hidrofílico.
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
WO2006034080A2 (en) * 2004-09-17 2006-03-30 Nektar Therapeutics Formulation comprising itraconazole
US20060240108A1 (en) * 2005-04-26 2006-10-26 Bernard Bobby L Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability
KR100771426B1 (ko) * 2006-02-03 2007-10-30 한국유나이티드제약 주식회사 마이크로펠렛을 이용한 약물학적 조성물 및 그의 제조방법
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US7314641B1 (en) * 2007-04-18 2008-01-01 Everest Pharm. Industrial Co., Ltd. High-bioavailability particle coated with fungicide and polymer
EP2044929A1 (de) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Schnell lösliche Tabletten für orale Anwendung
EP2044932A1 (de) 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Mechanische Schutzschicht für feste Darreichungsformen
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
WO2011119863A1 (en) * 2010-03-26 2011-09-29 Onconova Therapeutics, Inc. Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone
US9907812B2 (en) 2011-06-22 2018-03-06 Vyome Biosciences Pvt. Ltd. Conjugate-based antifungal and antibacterial prodrugs
EP2793833B1 (de) 2011-12-20 2020-06-24 Vyome Therapeutics Limited Topische ölzusammensetzung zur behandlung von pilzinfektionen
CN102658056B (zh) * 2012-04-20 2014-08-13 浙江新维普添加剂有限公司 一种用于维生素e醋酸酯乳化的复合乳化剂
EP2983714A2 (de) * 2013-04-12 2016-02-17 Vyome Biosciences Pvt. Ltd. Zusammensetzung und formulierung von antimikrobiellen wirkstoffen, verfahren dafür und verfahren zur behandlung mikrobieller infektionen
MX2015016675A (es) 2013-06-04 2016-07-15 Vyome Biosciences Pvt Ltd Particulas recubiertas y composiciones que comprenden las mismas.
WO2015118468A1 (en) * 2014-02-04 2015-08-13 Douglas Robert Cleverly Ectoparasite formulation
CN104688536B (zh) * 2015-02-03 2016-06-08 常州制药厂有限公司 一种伊曲康唑制剂的制备方法
WO2016144121A2 (ko) * 2015-03-12 2016-09-15 동아제약 주식회사 케라틴 조직의 진균감염증 치료를 위한 약제학적 조성물
KR101690765B1 (ko) * 2015-04-17 2016-12-28 동아제약 주식회사 항진균성 활성물질을 포함하는 경피 제제
CN113768885A (zh) * 2021-09-16 2021-12-10 海南海神同洲制药有限公司 一种伏立康唑干混悬剂的制备工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4267179A (en) 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4368200A (en) 1978-06-23 1983-01-11 Janssen Pharmaceutica N.V. Heterocyclic derivatives of (4-phenyl-piperazine-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4503055A (en) 1979-03-26 1985-03-05 Janssen Pharmaceutica, N.V. Derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4791111A (en) 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US4916134A (en) 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
US5223268A (en) 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
CA2118254A1 (en) * 1992-08-27 1994-03-17 Craig John Hubbard An ankle brace
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
PH31594A (en) 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
GB9509631D0 (en) 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
JP5370698B2 (ja) * 2011-06-16 2013-12-18 コニカミノルタ株式会社 画像形成システム及びこれを用いた後処理方法

Also Published As

Publication number Publication date
US20020176894A1 (en) 2002-11-28
EP1350508B8 (de) 2006-03-08
US6673373B2 (en) 2004-01-06
CN1303982C (zh) 2007-03-14
EP1350508B1 (de) 2005-11-16
CN1449744A (zh) 2003-10-22
ATE309790T1 (de) 2005-12-15
JP2003300907A (ja) 2003-10-21
DE60302268T2 (de) 2006-08-03
EP1350508A1 (de) 2003-10-08
KR20030079766A (ko) 2003-10-10

Similar Documents

Publication Publication Date Title
DE60302268D1 (de) Fungizide Zubereitung und Methoden zu ihrer Herstellung und Verwendung
EP1894567A4 (de) Pharmazeutische begleittherapien und ihre verwendung
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
ATE480539T1 (de) Bizyklische pyrazole wirksam als kinase inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE346058T1 (de) Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
ATE403648T1 (de) Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
ATE364620T1 (de) Amphotere sterole und deren verwendung
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
NO20085078L (no) Nye forbindelser
RS50360B (sr) Farmaceutske formulacije derivata platine
WO2003008407A3 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
ATE450533T1 (de) Carboxamidderivate
AR023939A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA uTILES COMO ANTAGONISTAS DE CCR5, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN, EL USO DE LOS MISMOS SOLOS O EN COMBINACIoN CON OTRO AGENTE ANTIVIRAL PARA LA PREPARACIoN DE UN MEDICAMENTO Y UN KIT
WO2004019912A3 (en) Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
DE60222178D1 (de) Neue substituierte pyrazolderivate, verfahren zu deren herstellung und diese enthaltende herbizide zusammensetzung
NO20061702L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en ostrogen agonist/antagonist
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
SE0402762D0 (sv) Indazole sulphonamide derivatives
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
ATE353216T1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
WO2004100865A3 (en) New benzimidazole derivatives
DE602004011966D1 (en) Heterocyclylverbindungen
DE60229046D1 (de) Chinazolin derivate
DE60217843D1 (de) Ein dioxinoä2,3-güchinolin-9-carbonsäure derivat als nk3 rezeptor antagonist

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: YUNG-SHIN PHARMA IND., CO. LTD., TACHIA, TAICHUNG,

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee